Skip to main content
OpenTrials

Clinical trial condition

Grade 3b Follicular Lymphoma

Explore clinical trials studying Grade 3b Follicular Lymphoma. Study availability and eligibility vary by location and protocol.

10 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Grade 3b Follicular Lymphoma trial results

Recruiting

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

NCT05633615

Conditions
Diffuse Large B-cell Lymphoma, Grade 3b Follicular Lymphoma, Hemic and Lymphatic Diseases, +15 more
Locations
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • Highlands Oncology Group - Fayetteville Fayetteville, Arkansas, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
View all 87 locations
View Trial Details
Recruiting

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

NCT05890352

Conditions
Grade 3b Follicular Lymphoma, Hemic and Lymphatic Diseases, High Grade B-Cell Lymphoma, +14 more
Locations
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
View all 104 locations
View Trial Details
Active, Not Recruiting

Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma

NCT04799275

Conditions
Ann Arbor Stage III Diffuse Large B-Cell Lymphoma, Ann Arbor Stage IIX (Bulky) Diffuse Large B-Cell Lymphoma, Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma, +30 more
Locations
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Kaiser Permanente-Anaheim Anaheim, California, United States
View all 176 locations
View Trial Details
Active, Not Recruiting

Acalabrutinib + Liso-Cel In R/R Aggressive B-Cell Lymphomas

NCT05583149

Conditions
Aggressive B-cell NHL, C-MYC/BCL2 Double-Hit High-Grade B-Cell Lymphoma, C-MYC/BCL6 Double-Hit High-Grade B-Cell Lymphoma, +27 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth-Israel Deaconess Medical Center Boston, Massachusetts, United States
View Trial Details

Related conditions